InvestorWire NewsRoom


Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) Leverages Genetic Technology to Produce First-In-Class Medical Grade Cannabis
July 20, 2021

Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) Leverages Genetic Technology to Produce First-In-Class Medical Grade Cannabis

  • Science continues to substantiate use of cannabis for pain relief, epileptic seizure control
  • Research suggests strains with optimized cannabinoid profiles are more effective 
  • PACR produces premium top-quality strains cultivated using genetics-first approach to optimize cannabinoid profiles
  • Genetic cultivation techniques allow selection for specific growing environments, maximum yields 

With a growing list of use cases spanning pain relief to seizure control, the medicinal use of cannabis goes back thousands of years ( Pac Roots Cannabis (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM), a Canadian cannabis company, leverages a genetics-focused approach to producing premium-quality strains with optimum cannabinoid profiles that are prized among consumers, including those in the hyper-growth medicinal space. 

Recent studies suggest that tetrahydrocannabinol (“THC”) and cannabidiol (“CBD”), along with hundreds of other potentially active compounds, can help relieve pain and control seizures. Referred to as “full-spectrum” cannabis, these specialized strains with optimized profiles were shown to be more effective due to the synergistic effect between specific cannabinoids and terpenes, organic compounds that enhance the effect of cannabis. 

Pac Roots leverages high-end genetics and specialized cultivars to produce distinctive cannabis products, specifically strains that can be tailored for medicinal purposes. This is made possible through Pac Roots’ exclusive partnership with Phenome One, a plant breeding management and analytics firm that gives the Company access to one of the largest live genetic libraries in Canada. 

Through Phenome One’s platform, Pac Roots has access to a massive database detailing over 350 unique laboratory-analyzed and rigorously field-tested cannabis cultivars that support each stage of the breeding process. Supported by data going back over 30 years, Pac Roots is also able to produce top-quality anti-fungal strains that are bred to thrive in specific climates – including the Fraser Valley in British Columbia where the Company recently made a sizeable land purchase.

With its high-quality soil and favorable climate, the Fraser Valley Regional District is known worldwide as one of Canada’s most productive and intensively farmed areas. Pac Roots recently made the strategic purchase through a share purchase agreement that gave the Company outright ownership of 250 acres of land spread over nine parcels. 

“The addition of such a substantial package of land to our portfolio is a major step for PacRoots. We are pleased to have the opportunity to add significant acreage with an acquisitional cost base of $9,600 per acre,” said Pac Roots President and CEO Patrick Elliott ( “This land has no zoning restrictions and is not situated within the Agricultural Land Reserve, which provides for infinite development possibilities.”

Medicinal cannabis products are growing in popularity across all demographics because of increased consumer awareness and the growing body of scientific evidence. As consumer demand for medicinal cannabis increases, the ability to deliver top-quality strains with optimized cannabinoid profiles is growing in importance. Pac Roots’ novel genetics-based approach to producing premium-grade cannabis, along with its portfolio of pristine land and production assets, is positioning the company favorably as a leader in the rapidly growing industry. 

For more information, visit the company’s website at

NOTE TO INVESTORS: The latest news and updates relating to PACR are available in the company’s newsroom at

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published:

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(310) 299-1717

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).